The abstract is read at the publisher; the summary is JClub's.
A plasma proteomic model using 13 proteins plus clinical variables predicts insulin sensitivity (R² = 0.67) and improves cardiometabolic risk prediction in ~20,000 UK Biobank participants.
- Why it matters: Insulin resistance is linked to cardiometabolic disease, but its circulating molecular signatures and tissue sources are not fully mapped for scalable risk stratification.
- What they did: Multiworkflow proteomics profiled plasma from 161 individuals across clamp-defined insulin sensitivity, identifying 488 insulin-sensitivity–associated proteins; a 13-protein model (with IGFBP1, LEP, GDF15, PON3, LDLR, sex, HbA1c, and triglyceride-to-HDL ratio) was then tested in UK Biobank and an independent 1,700-person cohort.
- The result: In ~20,000 UK Biobank participants, the model predicted type 2 diabetes better than triglyceride-to-HDL ratio (concordance index 0.86 vs 0.74) and, unlike HbA1c, predicted hepatic, renal, cardiovascular and respiratory disease; in 1,700 individuals it outperformed fasting insulin resistance indices including HOMA-IR.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.